EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surface‐engineered bacteria in drug development

Charles Dahlsson Leitao iD, Stefan Ståhl, John Löfblom iD

Microbial Biotechnology · 2024-10 · 17 (10)

DOI: 10.1111/1751-7915.70033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 15.10.2024. Verfasst von Charles Dahlsson Leitao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden. Hauptthemen laut MEDLINE: Drug Development, Bacteria, Cell Surface Display Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial surface display in combination with fluorescence‐activated cell sorting is a versatile and robust system and an interesting alternative approach to phage display for the generation of therapeutic affinity proteins. The system enables real‐time monitoring and sorting of cell populations, which presents unique possibilities for drug development. It has been used to develop several affibody molecules currently being evaluated preclinically for the treatment and diagnosis of, for example, cancer and neurodegenerative diseases. Additionally, it can be implemented in other areas of drug design, such as for mapping epitopes and evolving enzyme specificities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentBacteriaCell Surface Display TechniquesFlow CytometryHumansMicroorganisms, Genetically-ModifiedDrug Discovery

Autor:innen und Institutionen

  • Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.

ORCID-Profile: Charles Dahlsson Leitao, John Löfblom

Zitieren

APA

Dahlsson Leitao, C., Ståhl, S., & Löfblom, J. (2024). Surface‐engineered bacteria in drug development. Microbial Biotechnology, 17(10). https://doi.org/10.1111/1751-7915.70033

Vancouver

Dahlsson Leitao C, Ståhl S, Löfblom J. Surface‐engineered bacteria in drug development. Microbial Biotechnology. 2024;17(10). doi:10.1111/1751-7915.70033

BibTeX
@article{DahlssonLeitao2024,
  author = {Dahlsson Leitao, Charles and Ståhl, Stefan and Löfblom, John},
  title = {Surface‐engineered bacteria in drug development},
  journal = {Microbial Biotechnology},
  year = {2024},
  volume = {17},
  number = {10},
  doi = {10.1111/1751-7915.70033}
}
Kostenlos starten →